Background: Prognostication after a stroke has important implications for care and for decisions made by patients and their families. It is not clear why clinicians, even experienced stroke neurologists, poorly estimate the risk of disability and death following stroke.
Methods: We analyzed the results from the Clinician Judgment versus Risk Score to predict Stroke Outcomes study in which each clinician estimated the risk of death and the risk of death or disability in 5 case-based ischemic stroke scenarios. We employed a mixed-effect linear model to disentangle the ability of clinicians to discriminate between poor and good prognosis cases (slope) from the calibration of quantitative estimates (intercept), and to assess for any effect of anchoring in the death or disability condition (through a comparison with the death condition).
Results: One hundred eleven clinicians made 1665 predictions. Clinicians were able to discriminate between cases with low and high risks of death (slope of .81, 95% confidence interval [CI] .70-.93), but the quantitative estimates were not well calibrated (intercept of 5.14, 95% CI 3.97-6.33). The discrimination was poorer (slope of .67, 95% CI .60-.75), but the calibration was better (intercept of -.34, 95% CI -5.43 to 4.98) in the death or disability estimates.
Conclusion: Poor stroke prognostication can be explained by poor calibration and an anchoring effect, which are both amenable to specific training interventions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.01.024 | DOI Listing |
Clin Appl Thromb Hemost
January 2025
Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Deep vein thrombosis (DVT) is a leading cause of death disability. DVT can be classified based on the location and extent of the clot into isolated distal DVT (iDDVT), isolated proximal DVT (iPDVT), or mixed DVT. The aim of this study is to explore the baseline characteristics and clinical outcomes of patients with different types of DVT.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Cambridge, Cambridge, Cambridgeshire, United Kingdom.
Background: In the context of heightened attention to dementia, research gaps persist in the seamless integration of clinical and non-clinical care, including long-term support. This study aims to examine potential gaps in social support for US adults with cognitive impairment, focusing on the transition before and after a dementia diagnosis.
Methods: In this ambidirectional cohort study, we examined data from the Health and Retirement Survey(HRS) for US adults over 50, using data from 2000 to 2018.
Alzheimers Dement
December 2024
Dementias Laboratory, National Institute of Neurology and Neurosurgery, Mexico City, DF, Mexico.
Background: Dementia is a syndrome highly prevalent in elderly. Genetic and health factors have been reported to be associated with their onset. There is evidence that some psychosocial factors may have a differential effect by sex, beyond biological or hormonal explanations, as loneliness and social isolation(SI).
View Article and Find Full Text PDFCrit Care Resusc
December 2024
Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.
Objective: Extracorporeal membrane oxygenation (ECMO) is a high-risk procedure with significant morbidity and mortality and there is an uncertain volume-outcome relationship, especially regarding long-term functional outcomes. The aim of this study was to examine the association between ECMO centre volume and long-term death and disability outcomes.
Design Setting And Participants: This is a registry-embedded observational cohort study.
Int J Biol Sci
January 2025
Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
As a leading cause of morbidity and mortality, fibrosis is the common pathway of various chronic inflammatory diseases in organs and causes death in a large number of patients. It can destroy the structure and function of organs and ultimately lead to organ failure, which is a major cause of disability and death in many diseases. However, the regulatory mechanism of organ fibrosis is not well clear and the lack of effective drugs and treatments, which seriously endangers human health and safety.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!